Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism

Clinical Endocrinology

Volumn 44, Issue 4, 1996, Pages 447-451

  Nakamura, Hirotoshi ^a   Mori, Tomoko ^a   Genma, Rieko ^a   Suzuki, Yoshikazu ^a   Natsume, Hiroko ^a   Andoh, Shinichiro ^a   Kitahara, Ryo ^a   Nagasawa, Shinsuke ^a   Nishiyama, Kozo ^a   Yoshimi, Teruya ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; PYRIDINOLINE; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL;

EID: 9244246259     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.691513.x     Document Type: Article

References (17)

1. Black, D., Duncan, A. & Robins, S. P. (1988) Quantitative analysis of the pyridinium cross-links of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Analytical Biochemistry, 169, 197-203.
2. Coindre, J. M., David, J. P., Riviere, L., Goussot, J. F., Roger, P., de Mascarel, A., & Meunier, P. J. (1986) Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Archives of Internal Medicine, 146, 48-53.
3. Delmas, P. D., Schlemmer, A., Gineytes, E., Riis, B. & Christiansen, C. (1991) Urinary excretion of pyridioline cross-links correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. Journal of Bone and Mineral Research, 6, 639-44.
4. Eastell, R., Hampton, L., Colwell, A., Green, J.R., Assiri, A.M.A., Hesp, R., Russell, R.G.G. & Reeve, J. (1990) Urinary collagen cross-links are highly correlated with radioisotopic measurements of bone resorption. In Osteroporosis (eds C. Cristiansen & K. Overgaard) pp. 469-470. Osteopress, Copenhagen.
5. Frevert, E. U., Biester, A., Muller, M. J., Schmidt, G. H., von zur Muhlen, A, & Brabant, G. (1994) Markers of bone metabolism during short-term administration of thyroxine in healthy volunteers. European Journal of Endocrinology, 131, 145-9.
6. Garnero, P., Gineyts, E., Arbault, P., Christiansen, C. & Delmas, P. (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. Journal of Bone and Mineral Research, 10, 641-9.
7. Garnero, P., Shih, W. J., Gineyts, E., Karpf, D. B. & Delmas, P. D. (1994a) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. Journal of Clinical Endocrinology & Metabolism, 79, 1693-700.
8. Garnero, P., Vassy, V., Bertholin, A., Riou, J. P. & Delmas, P. D. (1994b) Markers of bone turnover in hyperthyroidism and the effects of treatment. Journal of Clinical Endocrinology & Metabolism, 78, 955-9.
9. Harvey, R. D., McHardy, K. C., Reid, I. W., Paterson, F., Bewsher, P. D., Duncan, A. & Robins, S. P. (1991) Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. Journal of Clinical Endocrinology and Metabolism, 72, 1189-94.
10. Krolner, B., Jorgensen, J. V. & Nielsen, S. P. (1983) Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clinical Endocrinology, 18, 439-46.
11. MacLeod, J. M., McHardy, K. C., Harvey, R. D., Duncan, A., Reid, I. W., Bewsher, P. D. & Robins, S. P. (1993) The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clinical Endocrinology, 38, 49-53.
12. Ribot, C., Tremollieres, F., Pouilles, J. M. & Louvet, J. P. (1990) Bone mineral density and thyroid hormone therapy. Clinical Endocrinology, 33, 143-53.
13. Robins, S. P., Duncan, A. & Riggs, B. L. (1990) Direct measurement of free hydroxy-pyridinium cross-links of collagen in urine as new markers of bone resorption in osteoporosis. In Osteoporosis (eds. C. Cristiansen & K. Overgaard) pp. 465-68. Osteopress, Copenhagen.
14. Robins, S. P., Woitge, H., Hesley, R., Ju, J., Seyedin, S. & Seibel, M. J. (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. Journal of Bone and Mineral Research, 9, 1643-9.
15. Rosen, H. N., Moses, A. C., Gundberg, C., Kung, V. T., Seyedin, S. M., Chen, T., Holick, M. & Greenspan, S. L. (1993) Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans. Journal of Clinical Endocrinology and Metabolism, 77, 664-9.
16. Seyedin, S. M., Kung, V. T., Daniloff, Y. N., Hesley, R. P., Gomez, B., Nielsen, L. A., Rosen, H. N. & Zuk, R. F. (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. Journal of Bone & Mineral Research, 8, 635-41.
17. Uebelhart, D., Gineyts, E., Chapuy, M. C. & Delmas, P. D. (1990) Urinary excretion of pyridinium cross-links: a new marker of bone resorption in metabolic bone disease. Bone and Mineral, 8, 87-96.